Total Payments
$4,907
2024 Payments
$916.45
Companies
22
Transactions
245
Medicare Patients
11,683
Medicare Billing
$853,542
Payment Breakdown by Category
Food & Beverage$4,601 (93.8%)
Education$306.44 (6.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,601 | 241 | 93.8% |
| Education | $306.44 | 4 | 6.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $991.99 | 59 | $0 (2024) |
| Janssen Biotech, Inc. | $772.40 | 32 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $605.32 | 24 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $337.75 | 19 | $0 (2024) |
| Amgen Inc. | $211.96 | 11 | $0 (2021) |
| PFIZER INC. | $207.50 | 13 | $0 (2024) |
| Lilly USA, LLC | $206.23 | 13 | $0 (2022) |
| Regeneron Healthcare Solutions, Inc. | $183.77 | 8 | $0 (2024) |
| UCB, Inc. | $183.06 | 9 | $0 (2024) |
| Genentech USA, Inc. | $171.88 | 11 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $916.45 | 36 | SUN PHARMACEUTICAL INDUSTRIES INC. ($206.58) |
| 2023 | $885.50 | 43 | AbbVie Inc. ($201.88) |
| 2022 | $720.04 | 41 | ABBVIE INC. ($263.77) |
| 2021 | $586.99 | 31 | Janssen Biotech, Inc. ($193.98) |
| 2020 | $275.67 | 17 | Biofrontera Inc. ($53.83) |
| 2019 | $423.14 | 24 | Genentech USA, Inc. ($81.28) |
| 2018 | $475.52 | 27 | AbbVie, Inc. ($91.96) |
| 2017 | $624.18 | 26 | DUSA Pharmaceuticals, Inc. ($139.38) |
All Payment Transactions
245 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: Inflammation & Immunology | ||||||
| 11/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: Immunology | ||||||
| 11/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $35.93 | General |
| Category: Dermatology | ||||||
| 10/15/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $10.03 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Inflammation & Immunology | ||||||
| 09/24/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: DERMATOLOGY | ||||||
| 09/17/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $28.89 | General |
| Category: Immunology | ||||||
| 09/10/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: Inflammation & Immunology | ||||||
| 07/30/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: IMMUNOLOGY | ||||||
| 07/16/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: Immunology | ||||||
| 07/09/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $19.11 | General |
| Category: Immunology | ||||||
| 06/18/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | — | Education | In-kind items and services | $99.00 | General |
| 06/18/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Inflammation & Immunology | ||||||
| 06/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.30 | General |
| Category: Immunology | ||||||
| 05/22/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: IMMUNOLOGY | ||||||
| 05/07/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $29.03 | General |
| Category: Dermatology | ||||||
| 04/23/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $15.63 | General |
| Category: DERMATOLOGY | ||||||
| 04/16/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: DERMATOLOGY | ||||||
| 04/09/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.62 | General |
| Category: Immunology | ||||||
| 04/04/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $26.71 | General |
| Category: Dermatology | ||||||
| 04/02/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: DERMATOLOGY | ||||||
| 04/01/2024 | ABBVIE INC. | — | Education | In-kind items and services | $8.45 | General |
| 03/29/2024 | ABBVIE INC. | HUMIRA (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 2,872 | 4,254 | $669,263 | $205,049 |
| 2022 | 26 | 2,816 | 4,424 | $685,016 | $204,849 |
| 2021 | 26 | 2,839 | 4,347 | $690,393 | $211,162 |
| 2020 | 30 | 3,156 | 16,521 | $682,564 | $232,482 |
Total Patients
11,683
Total Services
29,546
Medicare Billing
$853,542
Procedure Codes
110
All Medicare Procedures & Services
110 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 744 | 916 | $158,841 | $50,949 | 32.1% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 117 | 120 | $69,793 | $25,858 | 37.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 299 | 348 | $67,432 | $20,883 | 31.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 222 | 249 | $53,941 | $17,727 | 32.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 432 | 524 | $67,268 | $17,459 | 26.0% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 54 | 73 | $24,957 | $6,922 | 27.7% |
| 12042 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | Office | 2023 | 27 | 27 | $16,061 | $6,179 | 38.5% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 64 | 67 | $31,393 | $6,070 | 19.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 291 | 1,182 | $15,061 | $5,597 | 37.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 134 | 155 | $16,766 | $5,464 | 32.6% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 48 | 48 | $25,661 | $5,038 | 19.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 82 | 136 | $13,063 | $4,929 | 37.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 47 | 58 | $14,242 | $4,592 | 32.2% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Office | 2023 | 18 | 18 | $10,905 | $4,281 | 39.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 47 | 47 | $10,095 | $3,077 | 30.5% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 25 | 27 | $9,299 | $2,982 | 32.1% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 21 | 23 | $8,163 | $2,982 | 36.5% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 32 | 36 | $10,171 | $2,780 | 27.3% |
| 11642 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 21 | 23 | $11,800 | $2,315 | 19.6% |
| 12034 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 7.6-12.5 cm | Office | 2023 | 11 | 11 | $7,036 | $2,262 | 32.1% |
| 11622 | Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 19 | 19 | $9,210 | $1,805 | 19.6% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 16 | 17 | $4,068 | $1,319 | 32.4% |
| 11402 | Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 14 | 14 | $4,598 | $1,032 | 22.4% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 18 | 30 | $3,278 | $878.07 | 26.8% |
| 69100 | Biopsy of ear | Office | 2023 | 16 | 16 | $2,955 | $828.89 | 28.1% |
About Dr. Current Patterson, MD
Dr. Current Patterson, MD is a Dermatology healthcare provider based in Sylva, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/13/2007. The National Provider Identifier (NPI) number assigned to this provider is 1407070824.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Current Patterson, MD has received a total of $4,907 in payments from pharmaceutical and medical device companies, with $916.45 received in 2024. These payments were reported across 245 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($4,601).
As a Medicare-enrolled provider, Patterson has provided services to 11,683 Medicare beneficiaries, totaling 29,546 services with total Medicare billing of $853,542. Data is available for 4 years (2020–2023), covering 110 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Dermatology
- Location Sylva, NC
- Active Since 04/13/2007
- Last Updated 09/30/2020
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1407070824
Products in Payments
- TREMFYA (Drug) $571.59
- SKYRIZI (Biological) $391.36
- ILUMYA (Biological) $319.32
- DUPIXENT (Biological) $285.88
- COSENTYX (Biological) $246.97
- Enbrel (Biological) $211.96
- TALTZ (Drug) $206.23
- Humira (Biological) $190.01
- HUMIRA (Biological) $183.80
- RINVOQ (Biological) $172.21
- Erivedge (Biological) $171.88
- Cimzia (Drug) $166.81
- EUCRISA (Drug) $142.66
- Levulan (Drug) $139.38
- VTAMA (Drug) $115.55
- Sotyktu (Drug) $112.98
- Tremfya (Drug) $97.32
- AMELUZ (Drug) $92.09
- Xeomin (Biological) $80.91
- REMICADE (Biological) $77.81
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.